Browse All

Current Filters

CLEAR FILTER x

TITLE

Author:

Fremanezumab for Migraine Prevention: Interim Analysis of the Non-Interventional FINESSE Study

Author:Straube, Andreas   Brössner, Gregor   Gaul, Charly   Hamann, Xenia   Kraya, Torsten   Schauerte, Isabel   Neeb, Lars   

Session Name:P13: Headache: Towards Precision Medicine 3  

Topic:Headache  

Program Number:P13.010  

Author Institution:Ludwig-Maximilians-University Munich, Munich, Germany  Medical University of Innsbruck, Innsbruck, Austria  Headache Center Frankfurt, Frankfurt am Main, Germany  Teva GmbH, Ulm, Germany  St. Georg Hospital/ Headache Center Halle, Leipzig, Germany  Institut Dr. Schauerte, Munich, Germany  Department of Neurology, Charité Universitätsmedizin Berlin/Helios Global Health Berlin  

Initiating dopamine agonists rather than levodopa in early Parkinson’s disease does not delay the need for DBS.

Author:Olszewska, Diana Angelika   Fasano, Alfonso   Munhoz, Renato P   Ramirez Gomez, Carolina Candelaria   Lang, Anthony E   

Session Name:P13: Movement Disorders: Non Surgical Therapeutics in Parkinson's Disease 1  

Topic:Movement Disorders  

Program Number:P13.011  

Author Institution:Toronto Western Hospital, Toronto, ON, Canada  Hospital General Regional #1 Carlos Mac Gregor Sanchez, Mexico City, Mexico  

Effect of Eptinezumab on Utility Scores in Patients with Migraine: Results from the DELIVER Study

Author:Jonsson, Linus   Regnier, Stephane A   Kymes, Steven   Talon, Brian   Awad, Susanne F   Lee, Xin Ying   Goadsby, Peter J   

Session Name:P13: Headache: Towards Precision Medicine 3  

Topic:Headache  

Program Number:P13.011  

Author Institution:Department for Neurobiology, Care Sciences and Society, Division of Neurogeriatrics, Karolinska Institutet, Solna, Sweden  H. Lundbeck A/S, Copenhagen, Denmark  Lundbeck LLC, Deerfield, IL  NIHR-King’s Clinical Research Facility, King’s College London, London, United Kingdom  

Severity of Symptoms Among Persons With Multiple Sclerosis by PDDS Score

Author:Bonine, Nicole   Geiger, Caroline   Di Felice, Vanessa   Salter, Amber   

Session Name:P13: MS Clinical Assessments and Outcome Measures  

Topic:MS and Inflammatory Disease  

Program Number:P13.011  

Author Institution:Genentech, Inc., South San Francisco, CA  UT Southwestern Medical Center, Dallas, TX  

Characterizing the Impact of NMOSD on Mobility, Daily Activities, and Social Activities Through Patient Interviews

Author:Bernitsas, Evanthia   Osborne, Benjamin   Taylor, Natalie   Zeng, Fanyang   Anatchkova, Milena   Kielhorn, Adrian   

Session Name:P13: Autoimmune Neurology: NMOSD / MOGAD / Optic Neuritis  

Topic:Autoimmune Neurology  

Program Number:P13.011  

Author Institution:Wayne State School of Medicine, Detroit, MI  MedStar Georgetown University Hospital, Washington, DC  Evidera, Bethesda, MD  Alexion, AstraZeneca Rare Disease, Boston, MA